Emergent BioSolutions
EBS
#6766
Rank
โ‚ฌ0.54 B
Marketcap
10,22ย โ‚ฌ
Share price
-1.24%
Change (1 day)
18.25%
Change (1 year)

Emergent BioSolutions (EBS) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ0.56 Billion

According to Emergent BioSolutions 's latest financial reports the company's total debt is โ‚ฌ0.56 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Emergent BioSolutions - Total debt on balance sheet (from 2004 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ0.63 B-18.04%
2023-12-31โ‚ฌ0.77 B-40.63%
2022-12-31โ‚ฌ1.31 B76.48%
2021-12-31โ‚ฌ0.74 B4.41%
2020-12-31โ‚ฌ0.71 B-1.8%
2019-12-31โ‚ฌ0.72 B4.27%
2018-12-31โ‚ฌ0.69 B6073.32%
2017-12-31โ‚ฌ11.25 M-95.59%
2016-12-31โ‚ฌ0.25 B12.88%
2015-12-31โ‚ฌ0.22 B9.41%
2014-12-31โ‚ฌ0.20 B359.7%
2013-12-31โ‚ฌ44.89 M-5.4%
2012-12-31โ‚ฌ47.45 M3.66%
2011-12-31โ‚ฌ45.78 M28.4%
2010-12-31โ‚ฌ35.65 M-22.27%
2009-12-31โ‚ฌ45.86 M12.14%
2008-12-31โ‚ฌ40.9 M3.09%
2007-12-31โ‚ฌ39.67 M22.41%
2006-12-31โ‚ฌ32.41 M222.4%
2005-12-31โ‚ฌ10.05 M5.99%
2004-12-31โ‚ฌ9.48 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Merck
MRK
โ‚ฌ35.53 B 6,139.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚ฌ0.5 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ20.49 B 3,498.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
โ‚ฌ2.25 M-99.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ52.26 B 9,076.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.66 B 2,474.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
โ‚ฌ0.33 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA